Investor Presentaiton slide image

Investor Presentaiton

Non-IFRS adjustments in EBITDA Deferred revenue adjustments Other non-IFRS adjustments €m Q4 20 Q419 FY20 FY19 €m Q4 20 Q419 FY 20 FY19 Billings 128.1 100.6 460.3 324.9 Total IFRS 2 charges (14.8) (9.7) (48.9) (36.8) TeamViewer LTIP (0.6) (1.6) Perpetual def. revenue 6.5 28.7 46.2 124.5 Release/(Addition) Ubimax share consideration (7.2) (10.5) Share-based compensation by TLO (6.9) (9.7) (36.8) (36.8) Subscription def. revenue (13.9) (21.3) Release/(Addition) (48.5) (56.7) Other material items (2.3) (5.1) (5.7) (21.0) Financing, M&A, transaction-related (0.8) (0.0) (1.8) (0.6) Unallocated def. revenue 0.2 Release/(Addition) (1.1) (2.3) (2.6) IPO related (0.8) 0.0 (10.8) Other (1.5) (4.2) (3.9) (9.6) Revenue 121.0 106.9 455.6 390.2 USD hedge valuation gain/loss 1.9 3.0 Perpetual deferred revenue now largely released with €2.7m remaining on balance sheet (see next page) Total (15.1) (14.8) (51.6) (57.9) • Unallocated deferred revenue mainly consists of undue billings not recognized as receivables under IFRS 15 • TeamViewer cash-settled LTIP includes executive and key employee grants Ubimax share consideration recognized under IFRS 2 due to vesting condition with respect to continued employment of management Share-based compensation by TigerLux One (TLO) are fully funded by the selling shareholder in the IPO 26 Q4/ FY 2020 Preliminary Results (unaudited) - Investor Presentation TeamViewer
View entire presentation